OCUL·67576A100·US·equity·Healthcare - Biotechnology-13D/G
OCUL (OCULAR THERAPEUTIX INC) is held by 138 institutional investors as of Q1 2026. Largest holders: FMR LLC ($276.6M), BlackRock, Inc. ($136.6M), Avoro Capital Advisors LLC ($104.3M). Net institutional sentiment: Mixed.
See how OCUL's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer